Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.73 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | CD69 | Q07108 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL791244 | 0.88 | MAPK1 (0.79) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL61395 | 0.86 | MAPK1 (0.75) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL769616 | 0.85 | MAPK1 (0.55) | MAPK1NOD2ALDH1A1THRBLGALS3 | |
| SCHEMBL13575286 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL6552473 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL15504324 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL14520991 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL57604 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL20516489 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 | |
| SCHEMBL57603 | 0.85 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBCD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291893-A1 | CORONAL PROTEIN-COATED NANOPARTICLES AND USES THEREOF | University of Central Florida Research Foundation, Inc. (US) | 2023-12-20 | — | — | EP | claimed |
| WO-2023238881-A1 | MARKER FOR DIAGNOSING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR NON-ALCOHOLIC STEATOHEPATITIS (NASH) | 日東電工株式会社 | 2023-12-14 | — | — | WO | claimed |
| EP-4185705-A1 | COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS | Amunix Pharmaceuticals, Inc. (US) | 2023-05-31 | — | — | EP | claimed |
| EP-3452491-A1 | QUANTITATIVE PROFILING OF PROGESTERONE METABOLITES FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY | Indiana University Research & Technology Corporation (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2017192668-A1 | QUANTITATIVE PROFILING OF PROGESTERONE METABOLITES FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2017-11-09 | — | — | WO | claimed |
| WO-2014001571-A1 | COMPOSITION FOR USE IN MYCOBACTERIA DIAGNOSIS | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | claimed |
| WO-2014001572-A1 | COMPOSITION FOR USE IN MYCOBACTERIA THERAPY | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | claimed |
| WO-2014001570-A1 | COMPOSITION FOR USE IN MYCOBACTERIA VACCINATION | LYSANDO AG (LI) | 2014-01-03 | — | — | WO | claimed |
| WO-2013025759-A1 | PEPTIDE AND PROTEIN BIOMARKERS FOR TYPE 1 DIABETES MELLITUS | BATTELLE MEMORIAL INSTITUTE (US) | 2013-02-21 | — | — | WO | claimed |
| JP-2012500015-A | — | — | 2012-01-05 | — | — | JP | claimed |
| WO-2010141469-A2 | PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR AUTOIMMUNE AND ALLOIMMUNE DISEASES | CASE WESTERN RESERVE UNIVERSITY (US) | 2010-12-09 | — | — | WO | claimed |
| WO-2010020657-A1 | ARTIFICIAL PEPTIDOGLYCAN LYSING ENZYMES AND PEPTIDOGLYCAN BINDING PROTEINS | PROFOS AG (DE) | 2010-02-25 | — | — | WO | claimed |
| WO-2006130925-A1 | GENETIC MANIPULATION OF CLOSTRIDIUM DIFFICILE | MONASH UNIVERSITY (AU) | 2006-12-14 | — | — | WO | claimed |
| EP-4388077-A1 | POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS | Danisco US Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240197794-A1 | PROBIOTIC BACTERIAL STRAINS PRODUCING ANTIMICROBIAL PROTEINS AND COMPOSITIONS COMPRISING THESE FOR USE IN THE TREATMENT OF DIARRHEAL AND OTHER MICROBIAL DISEASES | CRIGASSENI AG (CH) | 2024-06-20 | — | — | US | disclosed |
| US-12005099-B2 | Targeted antimicrobials and related compositions, methods and systems | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-06-11 | — | — | US | disclosed |
| WO-1991017256-A1 | AUTOLYSIS-RESISTANT STRAINS AND METHODS EMPLOYING SAME | THE ROCKEFELLER UNIVERSITY (US) | 1991-11-14 | — | — | WO | disclosed |
| EP-0324018-A1 | PRODUCTION OF LYSIN-FREE PHAGE INOCULUM AND PRODUCTION OF LYSIN | IGENE BIOTECHNOLOGY, INC. (US) | 1989-07-19 | — | — | EP | disclosed |
| EP-0324018-A4 | PRODUCTION OF LYSIN-FREE PHAGE INOCULUM AND PRODUCTION OF LYSIN. | IGENE BIOTECHNOLOGY INC (US) | 1989-06-27 | — | — | EP | disclosed |
| WO-1989001030-A1 | PRODUCTION OF LYSIN-FREE PHAGE INOCULUM AND PRODUCTION OF LYSIN | IGENE BIOTECHNOLOGY, INC. (US) | 1989-02-09 | — | — | WO | disclosed |